Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Arkansas
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Post Menopausal Breast cancer patients with planned treatment of aromatase inhibitors.
18 years or older
You may not be if
BMI \>30 or \<18
Osteoporosis as defined by protocol.
Subjects currently on bisphosphonate therapy.
History of primary or secondary hyperparathyroidism
History of Hypo-or Hyperthyroidism
History of Vitamin D levels below LLN
History of creatinine clearance below the EGFR
History ofLiver function tests above 1.5 times ULN including LDH, SGOT, SGPT, Alkaline phosphatase, and Bilirubin
History of documented cirrhosis of the liver
History of chronic heparin use
History of chronic glucocorticoid therapy
Clareo Health | Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors
